Vineet Laboratories (NSE:VINEETLAB) 3-Year RORE % : 75.33% (As of Dec. 2025)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
41 GF Score
Price ₹32.21
GF Value ₹15.29
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories 3-Year RORE %?

Vineet Laboratories NSE:VINEETLAB -1.38% 41 3-Year RORE % is 75.33 as of Dec. 2025. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 41/100 and a GF Value™ of ₹15.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,519 Chemicals companies, Vineet Laboratories ranks better than 86.77% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Vineet Laboratories's 3-Year RORE % for the quarter that ended in Dec. 2025 was 75.33%.

The industry rank for Vineet Laboratories's 3-Year RORE % or its related term are showing as below:

NSE:VINEETLAB's 3-Year RORE % is ranked better than
86.77% of 1519 companies
in the Chemicals industry
Industry Median: 6.13 vs NSE:VINEETLAB: 75.33

Vineet Laboratories  (NSE:VINEETLAB) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Vineet Laboratories 3-Year RORE % Related Terms


Vineet Laboratories 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories 3-Year RORE % Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -82.43 114.35

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.23 114.35 85.91 158.09 75.33

NSE:VINEETLAB vs DOW: 3-Year RORE % Comparison

For the Chemicals subindustry, Vineet Laboratories's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories 3-Year RORE % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's 3-Year RORE % falls into.


NSE:VINEETLAB
41GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories 3-Year RORE % Calculation

Vineet Laboratories's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -7.431-2.412 )/( -13.066-0 )
=-9.843/-13.066
=75.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 75.33 mean?
Vineet Laboratories (NSE:VINEETLAB) has a 3-Year RORE % of 75.33 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Vineet Laboratories and its competitors. According to the industry distribution chart, Vineet Laboratories ranks #201 out of 1519 companies in the Chemicals industry, placing it in the top 13.2%.
Is Vineet Laboratories' 3-Year RORE % too high?
Vineet Laboratories' current 3-Year RORE % is 75.33. The Chemicals industry median 3-Year RORE % is 6.13. Vineet Laboratories' value of 75.33 is 1128.9% above this industry median. Based on the distribution chart, Vineet Laboratories ranks #201 out of 1519 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Vineet Laboratories has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' 3-Year RORE % compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #201 out of 1519 companies for 3-Year RORE %. This places Vineet Laboratories in the top 13% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 6.13. Vineet Laboratories' value of 75.33 is 1128.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Chemicals company?
The median 3-Year RORE % among Chemicals companies is 6.13, based on 1,519 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current 3-Year RORE % of 75.33 is 1128.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median 3-Year RORE % is 6.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current 3-Year RORE % is 75.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.29, compared to a current price of ₹32.21 — trading 110.7% above its estimated fair value. The current 3-Year RORE % is 75.33 and 1128.9% above the Chemicals industry median of 6.13. Vineet Laboratories' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current 3-Year RORE % is 75.33 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹32.21 is trading 110.7% above its estimated GF Value™ of ₹15.29. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • 3-Year RORE %: 75.33
  • GF Value™: ₹15.29 vs. price of ₹32.21 (110.7% above fair value)
  • GF Score™: 41/100 with 6 warning signs
  • Industry Position: 1128.9% above the Chemicals median (#201 of 1519)

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
41GF Score

Get the complete analysis for NSE:VINEETLAB

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.21
Price
₹15.29
GF Value